People with newly diagnosed Alzheimer’s disease less likely to have cataract surgery than unaffected people.
The prevalence of Alzheimer’s disease (AD) has increased globally during the last decades. It is well known that suboptimal care of comorbidities can accelerate the course of cognitive decline in AD.
One of these comorbidities, poor vision, is associated with cognitive decline. The most common cause of poor vision and vision loss is cataract, where the opacity of the crystalline lens of the eye is lost. The only Alzheimer’s Disease treatment is rather mini-invasive surgery.
People with Alzheimer’s disease (AD) are less likely to have cataract surgery than people without Alzheimer’s disease. The procedure rate starts to decrease already one year after the diagnosis, according to a new study from the University of Eastern Finland.
The lower likelihood of cataract surgery among people with cognitive disorders has been reported previously. This study is the first to report an association between the AD diagnosis and a lower incidence of cataract surgery, and a decrease in the procedure rate related to the time since the diagnosis.
The decrease in the incidence of cataract surgery among people with newly diagnosed AD is concerning because the benefits of this low-risk procedure would probably be similar for people with and without AD.
“The results of the study indicate that people with AD might have a higher threshold for cataract procedures. However, persons with cognitive disorders should be actively referred to ophthalmologic consultations because cataract surgery can improve their cognitive and physical functioning. The stigma of the disease should not lead to fewer referrals to cataract surgery,” the authors say.
The study was conducted as part of the Medication Use and Alzheimer’s Disease Study (MEDALZ), in a cohort which includes 70,718 Finnish community dwellers with AD diagnosed between years 2005 and 2011. They were compared to persons of the same age and gender without AD.
more recommended stories
Kidney Tissue Repair Enhanced by AD-NP1 in Preclinical StudyKey Summary UCLA researchers found that.
Mazdutide Shows Significant Weight Loss in Phase 3 TrialKey Summary Mazdutide, a dual GLP-1.
Fatherhood Linked to Lower Mortality Risk in Black MenKey Summary A new longitudinal study.
Strength Training May Reduce Mortality Risk, Study FindsKey Summary A 30-year study involving.
New Alzheimer’s Drugs Raise Questions for RegulatorsKey Points Summary New Alzheimer’s drugs.
Pregnancy Nausea May Signal Anxiety and Depression RiskKey Summary A prospective study published.
Ebola Outbreak in DRC and Uganda Triggers WHO EmergencyKey Points Summary The World Health.
PCOS Renamed to PMOS to Reflect Broader Health RisksKey Points The World Health Organization.
Walking 8,500 Steps May Prevent Weight RegainKey Points A new meta-analysis presented.
Hantavirus Cruise Ship Outbreak: WHO Issues UpdateKey Points WHO confirmed a cluster.

Leave a Comment